article · International Journal of Adolescent Medicine and Health

Waist-height ratio highlights detrimental risk for olanzapine associated weight gain earlier than body mass index

Ibrahim Mohammed Badamasi
Mujittapha U. Sirajo
Margaret Isioma Ojeahere
Abiola Tajudeen
Shakirat D. Owolabi
Adebimpe Olukemi Yusuf
Mustapha I. Gudaji

2024University of Jos

Abstract

Our results underscore the critical importance of WHtR in assessing adiposity among schizophrenia patients treated with olanzapine, highlighting its value as a tool for monitoring and managing cardiometabolic risks in this population.

Research topics

Diet and metabolism studies
Schizophrenia research and treatment
Bipolar Disorder and Treatment

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1515/ijamh-2024-0099

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.